A detailed history of Brandywine Global Investment Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 383,957 shares of JAZZ stock, worth $42.6 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
383,957
Previous 436,557 12.05%
Holding current value
$42.6 Million
Previous $52.6 Million 22.05%
% of portfolio
0.31%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $5.47 Million - $6.26 Million
-52,600 Reduced 12.05%
383,957 $41 Million
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $6.05 Million - $6.98 Million
52,537 Added 13.68%
436,557 $52.6 Million
Q4 2023

Feb 09, 2024

BUY
$114.26 - $136.0 $3.07 Million - $3.65 Million
26,846 Added 7.52%
384,020 $47.2 Million
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $2.22 Million - $2.64 Million
-18,176 Reduced 4.84%
357,174 $46.2 Million
Q2 2023

Aug 11, 2023

SELL
$122.5 - $147.16 $1.59 Million - $1.91 Million
-12,967 Reduced 3.34%
375,350 $46.5 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $6.27 Million - $7.51 Million
46,769 Added 13.69%
388,317 $56.8 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $1.61 Million - $1.99 Million
12,437 Added 3.78%
341,548 $54.4 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $744,096 - $947,416
-5,878 Reduced 1.75%
329,111 $43.9 Million
Q2 2022

Aug 11, 2022

SELL
$141.59 - $168.66 $725,790 - $864,551
-5,126 Reduced 1.51%
334,989 $52.3 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $1.29 Million - $1.6 Million
-9,944 Reduced 2.84%
340,115 $52.9 Million
Q4 2021

Feb 11, 2022

BUY
$119.87 - $145.67 $1.1 Million - $1.34 Million
9,170 Added 2.69%
350,059 $44.6 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $18 Million - $25.8 Million
139,619 Added 69.37%
340,889 $44.4 Million
Q2 2021

Aug 13, 2021

SELL
$160.2 - $186.42 $10.1 Million - $11.7 Million
-62,905 Reduced 23.81%
201,270 $35.8 Million
Q1 2021

May 13, 2021

BUY
$150.19 - $173.5 $7.07 Million - $8.17 Million
47,074 Added 21.68%
264,175 $43.4 Million
Q4 2020

Feb 10, 2021

SELL
$140.71 - $165.05 $9.48 Million - $11.1 Million
-67,375 Reduced 23.68%
217,101 $35.8 Million
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $369,215 - $504,599
-3,501 Reduced 1.22%
284,476 $40.6 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $4.61 Million - $5.87 Million
48,145 Added 20.07%
287,977 $31.8 Million
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $10.8 Million - $18.8 Million
-123,064 Reduced 33.91%
239,832 $23.9 Million
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $2.68 Million - $3.5 Million
-22,771 Reduced 5.9%
362,896 $53.9 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $868,874 - $994,228
-6,941 Reduced 1.77%
385,667 $49.4 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $10.5 Million - $12.1 Million
83,658 Added 27.08%
392,608 $56 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $13.4 Million - $15.8 Million
110,351 Added 55.56%
308,950 $44.2 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $787,696 - $1.13 Million
6,794 Added 3.54%
198,599 $24.6 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $933,858 - $1.05 Million
-5,800 Reduced 2.94%
191,805 $32.2 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $1.21 Million - $1.52 Million
-8,300 Reduced 4.03%
197,605 $34 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $429,955 - $498,354
-3,171 Reduced 1.52%
205,905 $31.1 Million
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $876,660 - $1.01 Million
-6,689 Reduced 3.1%
209,076 $28.2 Million
Q3 2017

Nov 14, 2017

SELL
$142.62 - $155.6 $399,336 - $435,680
-2,800 Reduced 1.28%
215,765 $31.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
218,565
218,565 $34 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.95B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.